The FDA has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 antibody, for the treatment of celiac disease.

Patients with IBD in rural areas are significantly less likely to receive advanced therapies and multidisciplinary care compared with their urban counterparts.

Federal health officials pulled back a key recommendation that pregnant women get the COVID-19 vaccine, causing sharp criticism from experts.

Hormel Foods is recalling more than 256,000 pounds of its Dinty Moore Beef Stew amid reports that wood fragments were found in some cans.

In a retrospective study, overlapping biologic therapy for ulcerative colitis or Crohn disease did not significantly increase risk of infections.

The Food and Drug Administration has designated Hadlima (adalimumab-bwwd) an interchangeable biosimilar to Humira (adalimumab).

For patients with BRAF V600E-mutated metastatic CRC, overall survival significantly longer with encorafenib + cetuximab + chemotherapy.

Gut-directed hypnotherapy reduces overall symptom burden and abdominal pain in those with irritable bowel syndrome, according to a recent study.

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

Exposure to antibiotics following FMT may lead to recurrent CDI, suggesting the need for modified strategies to prevent recurrent CDI in some patients.